Denis Beckford Vera, head of Radiopharmacology, Champion Oncology explains how patient-derived xenografts improve drug ...
Ligand Pharma (LGND) outperforms via a high-margin royalty model and disciplined investing. Click here to read my most recent ...
No longer limiting its military retaliation to strikes against Israel or U.S. military installations, Iran has expanded the battlefield dramatically by directly targeting vital infrastructure in ...
The Trump administration relied on rosy price estimates to argue that repealing emissions limits for cars would save ...
From Selection Sunday to the Championship, track every team's odds of advancing through each round of the Men's NCAA ...
The Calamos Phineus Long/Short Fund (Class I shares at NAV) declined -1.32% in Q4 on an average net equity exposure of 16.6%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results